Related Experiment Video
Updated: Aug 6, 2025
10:40
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
2.5K
KRAS Hijacks the miRNA Regulatory Pathway in Cancer
Angelina S Bortoletto1, Ronald J Parchem1
1Center for Cell and Gene Therapy, Stem Cell and Regenerative Medicine Center, Department of Molecular and Cellular Biology, Department of Neuroscience, Translational Biology and Molecular Medicine Program, Medical Scientist Training Program, Baylor College of Medicine, Houston, Texas.
Cancer Research
|March 22, 2023
Summary
Mutations in microRNA (miRNA) processing machinery and oncogenic Kristen rat sarcoma viral oncogene homolog (KRAS) promote cancer by disrupting miRNA regulation. Targeting both offers a potential therapeutic strategy.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- MicroRNAs (miRNAs) are key regulators of gene expression implicated in cancer.
- Previous research focused on individual miRNA dysregulation.
- Emerging evidence links mutations in miRNA biogenesis machinery and oncogenic KRAS to cancer development.
Purpose of the Study:
- To highlight the role of miRNA core machinery mutations in cancer.
- To discuss how mutant KRAS impacts miRNA processing and function.
- To explore therapeutic strategies targeting mutant KRAS and miRNA machinery.
Main Methods:
- Review of existing literature on miRNA biogenesis, KRAS mutations, and cancer.
- Analysis of the interplay between KRAS signaling and miRNA regulatory pathways.
- Discussion of potential therapeutic interventions.
Main Results:
- Mutations in miRNA biogenesis machinery contribute to malignant transformation.
- Oncogenic KRAS modulates miRNA regulatory pathways, impacting multiple processing steps.
- Dysregulated miRNA processing by mutant KRAS promotes tumorigenesis.
Conclusions:
- Mutations in the miRNA core machinery are vital drivers of cancer.
- Mutant KRAS hijacks the miRNA pathway, adding complexity to its oncogenic role.
- Concurrent targeting of mutant KRAS and miRNA machinery presents a promising therapeutic avenue.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:22MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
02:38The Ras Gene
6.3K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.3K
01:07MAPK Signaling Cascades
5.7K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.7K
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
01:19Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K